Metis Global Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Sell |
8,052
-6,368
| -44% | -$176K | 0.01% | 700 |
|
|
2025
Q1 | $409K | Sell |
14,420
-5,656
| -28% | -$160K | 0.01% | 623 |
|
|
2024
Q4 | $835K | Buy |
20,076
+5,242
| +35% | +$218K | 0.03% | 480 |
|
|
2024
Q3 | $991K | Buy |
14,834
+1,814
| +14% | +$121K | 0.03% | 441 |
|
|
2024
Q2 | $1.55M | Buy |
13,020
+779
| +6% | +$92.5K | 0.05% | 316 |
|
|
2024
Q1 | $1.3M | Sell |
12,241
-141
| -1% | -$15K | 0.05% | 362 |
|
|
2023
Q4 | $1.23M | Sell |
12,382
-3,082
| -20% | -$307K | 0.05% | 357 |
|
|
2023
Q3 | $1.6M | Buy |
15,464
+2,493
| +19% | +$258K | 0.08% | 274 |
|
|
2023
Q2 | $1.58M | Buy |
12,971
+3
| +0% | +$365 | 0.08% | 250 |
|
|
2023
Q1 | $1.99M | Buy |
12,968
+3,431
| +36% | +$527K | 0.13% | 162 |
|
|
2022
Q4 | $1.71M | Buy |
9,537
+3,590
| +60% | +$645K | 0.15% | 146 |
|
|
2022
Q3 | $704K | Buy |
5,947
+386
| +7% | +$45.7K | 0.11% | 202 |
|
|
2022
Q2 | $794K | Buy |
5,561
+31
| +0.6% | +$4.43K | 0.13% | 186 |
|
|
2022
Q1 | $953K | Buy |
5,530
+2,450
| +80% | +$422K | 0.11% | 169 |
|
|
2021
Q4 | $782K | Buy |
+3,080
| New | +$782K | 0.22% | 104 |
|